Sulfadimethoxine

DB06150

small molecule approved vet_approved withdrawn

Deskripsi

Sulfadimethoxine is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections, including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies.

In the US, sulfadimethoxine is one of the products that have been withdrawn or removed from the market after being found to be unsafe or not effective.L43942

Struktur Molekul 2D

Berat 310.329
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfadimethoxine is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfadimethoxine.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfadimethoxine.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfadimethoxine.
Cyclosporine The risk or severity of renal failure can be increased when Sulfadimethoxine is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfadimethoxine.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfadimethoxine.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfadimethoxine.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfadimethoxine.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfadimethoxine.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Sulfadimethoxine.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfadimethoxine.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfadimethoxine.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfadimethoxine.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Sulfadimethoxine.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfadimethoxine.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfadimethoxine.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfadimethoxine.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfadimethoxine.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfadimethoxine.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfadimethoxine.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfadimethoxine.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfadimethoxine.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfadimethoxine.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfadimethoxine.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfadimethoxine.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfadimethoxine.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfadimethoxine.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfadimethoxine.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfadimethoxine.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfadimethoxine.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfadimethoxine.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfadimethoxine.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfadimethoxine.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfadimethoxine.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfadimethoxine.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfadimethoxine.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfadimethoxine.
Insulin aspart The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfadimethoxine.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfadimethoxine.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Sulfadimethoxine.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfadimethoxine.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfadimethoxine.
NN344 The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfadimethoxine.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfadimethoxine.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfadimethoxine.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfadimethoxine.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfadimethoxine.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfadimethoxine.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfadimethoxine.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfadimethoxine.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadimethoxine.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfadimethoxine.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfadimethoxine.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfadimethoxine.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfadimethoxine.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfadimethoxine.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfadimethoxine.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfadimethoxine.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfadimethoxine.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfadimethoxine.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfadimethoxine.
Insulin beef The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Sulfadimethoxine is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfadimethoxine.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfadimethoxine.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Sulfadimethoxine.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfadimethoxine.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfadimethoxine.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfadimethoxine.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfadimethoxine.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfadimethoxine.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfadimethoxine.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfadimethoxine.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfadimethoxine.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfadimethoxine.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfadimethoxine.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfadimethoxine.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfadimethoxine.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfadimethoxine.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfadimethoxine.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfadimethoxine.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfadimethoxine.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfadimethoxine.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfadimethoxine.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Abcid
  • Agribon

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul